Enfermedad por virus sincitial respiratorio en pediatría más allá del compromiso respiratorio
Respiratory syncytial virus disease in children: beyond respiratory involvement
Barra lateral del artículo
PDF
FLIP
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Contenido principal del artículo
Resumen
Introducción: el virus sincitial respiratorio (VSR) suele asociarse con la enfermedad respiratoria en la población pediátrica, sin embargo se han documentado múltiples manifestaciones extrapulmonares, en especial neurológicas. Objetivo: presentar un panorama de los reportes en la literatura indexada sobre el compromiso neurológico en la infección por VSR. Materiales y Métodos: revisión sistemática exploratoria formal de la literatura en las bases de datos Pubmed y SCOPUS, que incluyó estudios primarios y secundarios hasta el 17 de julio 2022, publicadas en inglés, español y francés. Resultados: se consideraron 30 publicaciones que describían la experiencia en 1.681 pacientes con una edad mediana de 17 meses y mayor compromiso del sexo masculino (64.59%), en el marco de la enfermedad respiratoria grave por VSR. Las convulsiones y la apnea central aparecieron como principales manifestaciones, ya sea por invasión viral e inflamación secundaria del sistema nervioso central (SNC) o por la compensación derivada de los ajustes neuroendocrinos ante el daño respiratorio severo. Las secuelas a largo plazo incluyeron retraso en el desarrollo y discapacidad cognitiva. Conclusión: el síndrome por infección respiratoria grave por VSR puede ocurrir con compromiso neurológico, posiblemente derivado de la acción directa del virus a nivel del SNC o de los efectos del proceso adaptativo. Estos dos mecanismos deben considerarse en presencia de enfermedad respiratoria grave por VSR que cursen con deterioro neurológico, para una correcta aproximación diagnóstica y manejo oportuno, con el fin de disminuir el riesgo de secuelas significativas.
Palabras clave:
Descargas
Detalles del artículo
Referencias
Griffiths C, Drews SJ, Marchant DJ. New options for prevention and treatment. Clin Microbiol Rev. 2017;30(1):277–319. https://doi.org/10.1128/CMR.00010-16
Yu J, Liu C, Xiao Y, Xiang Z, Zhou H, Chen L, et al. Respiratory syncytial virus seasonality, Beijing, China, 2007-2015. Emerg Infect Dis. 2019;25(6):1127–35. https://doi.org/10.3201/eid2506.180532
Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol. 2017;52(4):556–69. https://doi.org/10.1002/ppul.23570
Ospina Martíne ML, Prieto Alvarado FE, Walteros D, Quijada Bonilla H. Semana epidemiológica 40 - 29 de sep. al 5 de octubre de 2019. Infección Respiratoria Aguda. Colombia: Instituto Nacional de Salud. Boletín Epidemiológico Semanal; 2019. https://doi.org/10.33610/23576189.2019.40
Jain H, Schweitzer JW, Justice NA. Respiratory Syncytial Virus Infection. StatPearls; 2021.
Bohmwald K, Espinoza JA, Rey-Jurado E, et al. Human Respiratory Syncytial Virus: Infection and Pathology. Semin Respir Crit Care Med. 2016;37(4):522-537. https://doi.org/10.1055/s-0036-1584799
Mammas IN, Drysdale SB, Rath B, Theodoridou M, Papaioannou G, Papatheodoropoulou A, et al. Update on current views and advances on RSV infection (Review). Int J Mol Med. 2020;46(2):509-520. https://doi.org/10.3892/ijmm.2020.4641.
Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-1555. https://doi.org/10.1016/S0140-6736(10)60206-1
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol.2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616
Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.22. https://doi.org/10.1186/1748-5908-5-69
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https://doi.org/10.1186/s13643-016-0384-4
Grudniewicz A, Nelson M, Kuluski K, et al. Treatment goal setting for complex patients: protocol for a scoping review. BMJ Open. 2016;6(5):e011869.26. https://doi.org/10.1136/bmjopen-2016-011869
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.23. https://doi.org/10.7326/M18-0850
Hirayama K, Sakazaki H, Murakami S, et al. Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis. Pediatr Radiol. 1999;29(4):282-286. https://doi.org/10.1007/s002470050589
Picone S, Mondì V, Di Palma F, Martini L, Paolillo P. Neonatal Encephalopathy and SIADH during RSV Infection. Am J Perinatol. 2019;36(S02):S106-S109. https://doi.org/10.1055/s-0039-1692132
Sugimoto M, Morichi S, Kashiwagi Y, et al. A case of respiratory syncytial virus-associated encephalopathy in which the virus was detected in cerebrospinal fluid and intratracheal aspiration despite negative rapid test results. J Infect Chemother. 2020;26(4):393-396. https://doi.org/10.1016/j.jiac.2019.11.008
Rantala H, Uhari M, Tuokko H. Viral infections and recurrences of febrile convulsions. J Pediatr. 1990;116(2):195-199. https://doi.org/10.1016/s0022-3476(05)82874-4
Kho N, Kerrigan JF, Tong T, Browne R, Knilans J. Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J Child Neurol. 2004;19(11):859-864. https://doi.org/10.1177/08830738040190110301
Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32(5):307-310. https://doi.org/10.1016/j.pediatrneurol.2005.01.010
Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol. 2006;35(3):165-172. https://doi.org/10.1016/j.pediatrneurol.2006.06.004
Kawashima H, Ioi H, Ushio M, Yamanaka G, Matsumoto S, Nakayama T. Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand J Infect Dis. 2009;41(3):228-231. https://doi.org/10.1080/00365540802669543
Ong SCL, Nur Azidawati AH, Liew YH, Anita S. Acute necrotising encephalopathy of childhood: A review of two cases. Med J Malaysia. 2017;72(5):311-313.
Miyama S, Goto T. Afebrile seizures associated with respiratory syncytial virus infection: a situation-related seizure disorder in early infancy. Pediatr Int. 2011;53(1):113-115. https://doi.org/10.1111/j.1442-200X.2010.03188.x.
Cha T, Choi YJ, Oh JW, et al. Respiratory syncytial virus-associated seizures in Korean children, 2011-2016. Korean J Pediatr. 2019;62(4):131-137. https://doi.org/10.3345/kjp.2018.07066
Miyamoto K, Fujisawa M, Hozumi H, et al. Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy. J Infect Chemother. 2013;19(5):978-982. https://doi.org/10.1007/s10156-013-0558-0
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55. https://doi.org/10.1016/S0140-6736(10)60206-1
Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care. 2006;10(4):R107. https://doi.org/10.1186/cc4984
Soung A, Klein RS. Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes. Trends Mol Med. 2018;24(11):950–62. https://doi.org/10.1016/j.molmed.2018.09.001
Hoyer C, Eisele P, Ebert AD, Schneider S, Gass A, Fatar M, et al. Blood-CSF-barrier dysfunction is a marker for encephalitic involvement in patients with aseptic meningitis/meningoencephalitis. J Clin Virol. 2016;84:82–6. https://doi.org/10.1016/j.jcv.2016.10.006
El-Bitar MK, Boustany RM. Common causes of uncommon seizures. Pediatr Neurol. 2009;41(2):83-87. https://doi.org/10.1016/j.pediatrneurol.2009.04.011
Bohmwald K, Espinoza JA, González PA, Bueno SM, Riedel CA, Kalergis AM. Central nervous system alterations caused by infection with the human respiratory syncytial virus. Rev Med Virol. 2014;24(6):407-419. https://doi.org/10.1002/rmv.1813
Bohmwald K, Espinoza JA, Becerra D, et al. Inflammatory damage on respiratory and nervous systems due to hRSV infection. Curr Opin Immunol. 2015;36:14-21. https://doi.org/10.1016/j.coi.2015.05.003
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018;12:386. https://doi.org/10.3389/fncel.2018.00386
Robinson CP, Busl KM. Neurologic Manifestations of Severe Respiratory Viral Contagions. Crit Care Explor. 2020;2(4):e0107. https://doi.org/10.1097/CCE.0000000000000107
Erez DL, Yarden-Bilavsky H, Mendelson E, et al. Apnea induced by respiratory syncytial virus infection is not associated with viral invasion of the central nervous system. Pediatr Infect Dis J. 2014;33(8):880-881. https://doi.org/10.1097/INF.0000000000000311
Venkatesan A, Murphy OC. Viral Encephalitis. Neurol Clin. 2018;36(4):705–24. https://doi.org/10.1016/j.ncl.2018.07.001
Ferolla FM, Soffe J, Mistchenko A, Contrini MM, López EL. Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection. Arch Argent Pediatr. 2019;117(4):216-223 https://doi.org/10.5546/aap.2019.eng.216
Domachowske JB, Anderson EJ, Goldstein M. The Future of Respiratory Syncytial Virus Disease Prevention and Treatment. Infect Dis Ther. 2021;10(Suppl 1):47–60. https://doi.org/10.1007/s40121-020-00383-6